An Updated Analysis Of Phase 3 Gimema-MMY

Persistent Improvement In Clinical Outcomes With
Bortezomib-Thalidomide-Dexamethasone Vs ThalidomideDexamethasone Incorporated Into Double Autologous
Transplantation For Multiple Myeloma: An Updated
Analysis Of Phase 3 Gimema-MMY-3006 Study
by Michele Cavo, Monica Galli, Annalisa Pezzi, Francesco Di Raimondo, Claudia
Crippa, Massimo Offidani, Paola Tacchetti, Vittorio Montefusco, Franco Narni,
Antonio Spadano, Norbert Pescosta, Elena Zamagni, Barbara Gamberi, Tommaso
Caravita, Antonietta Pia Falcone, Chiara Nozzoli, Renato Zambello, Anna Furlan,
Annamaria Brioli, and Mario Boccadoro
Blood
Volume 122(21):2090-2090
November 15, 2013
©2013 by American Society of Hematology
Monica Galli et al. Blood 2013;122:2090
©2013 by American Society of Hematology
Monica Galli et al. Blood 2013;122:2090
©2013 by American Society of Hematology
Monica Galli et al. Blood 2013;122:2090
©2013 by American Society of Hematology
Monica Galli et al. Blood 2013;122:2090
©2013 by American Society of Hematology